SEARCH

SEARCH BY CITATION

REFERENCES

  • Armitage P, Berry G. (1994) The simple crossover design. In Statistical methods in medical research, 3rd ed. Blackwell Science, Cambridge , pp. 245248.
  • Beck O, Ohman I, Nordgren H. (2006) Determination of lamotrigine and its metabolites in human plasma by liquid chromatography-mass spectrometry. Therapeutic Drug Monitoring 28:603607.
  • Browning KR, Birnbaum AK, Montgomery JQ, Newman ML, Clements SD, Pennell PB. (2006) Lamotrigine clearance is increased by estrogen-containing oral contraceptives. Neurology 66(suppl 2):A73.
  • Crawford P. (2002) Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs 16:263272.
  • Dickins M, Chen C. (2002) Lamotrigine: chemistry, biotransformation and pharmacokinetics: In LevyRH (Ed) Antiepileptic drugs, 5th ed. Lippincott Williams & Wilkins, Philadelphia , pp. 370379.
  • Doose DR, Wang SS, Padmanabhan M, Schwabe S, Jacobs D, Bialer M. (2003) Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Epilepsia 44:540549.
  • Ebner T, Remmel RP, Burchell B. (1993) Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol. Molecular Pharmacology 43:649654.
  • French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA. (2004a) Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 45:401409.
  • French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA. (2004b) Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 45:410423.
  • Holdish T, Whiteman P, Orme M, Back D, Ward S. (1991) Effect of lamotrigine on the pharmacology of the combined oral contraceptive pill. Epilepsia 32(suppl):s96.
  • Hussein Z, Posner J. (1997) Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. British Journal of Clinical Pharmacology 43:457465.
  • Jorgensen A, Fabricius S, Nexo E, Djurhuus JC, Rosenberg R, Hammer U, Christiansen JS. (2000) The GCP-unit at the Aarhus University Hospital. Ugeskrift for Laeger 162:42884290.
  • Patsalos PN, Perucca E. (2003a) Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurology 2:347356.
  • Patsalos PN, Perucca E. (2003b) Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurology 2:473481.
  • Reimers A, Brodtkorb E, Helde G, Spigset O. (2006) Lamotrigine serum concentrations throughout the menstrual cycle: a study of 2 cases. Clinical Neuropharmacology 29:160162.
  • Reimers A, Helde G, Brodtkorb E. (2005) Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia 46:14141417.
  • Sabers A, Buchholt JM, Uldall P, Hansen EL. (2001) Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Research 47:151154.
  • Sabers A, Ohman I, Christensen J, Tomson T. (2003) Oral contraceptives reduce lamotrigine plasma levels. Neurology 61:570571.
  • Shipkova M, Wieland E. (2005) Glucuronidation in therapeutic drug monitoring. Clinical Chimica Acta 358:223.
  • Sidhu J, Job S, Singh S, Philipson R. (2006) The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. British Journal of Clinical Pharmacology 61:191199.
  • Tephly TR, Green MD. (2000) UDP-Glucuronosyltransferases. In LevyRH (Ed) Metabolic drug interactions. Lippincott Williams & Wilkins, Philadelphia , pp. 161174.